# Program 1: Breast Cancer

> **NIH NIH P30** · DANA-FARBER CANCER INST · 2020 · $73,870

## Abstract

Breast Cancer Program
Project Summary / Abstract
The primary goal of the Breast Cancer Program is to reduce mortality and morbidity from breast cancer.
The program is committed to research in four core areas that could have a significant impact on the
treatment of patients with breast cancer: 1) triple negative breast cancer, 2) HER2+ breast cancer, 3) brain
metastases, and 4) breast cancer arising in young women. Each of these areas builds on a strong research
base at DF/HCC and brings together investigators from several disciplines and multiple institutions. The
program has 116 members, representing seven DF/HCC institutions and 17 academic departments. In 2014
peer-reviewed grant funding attributed to the Program was $9.8 million in total costs from the NCI and $7.8
million from other sponsors. During the current funding period, Breast Cancer Program members published
1,750 cancer-relevant papers. Of these 33% were inter-institutional, 26% were intra-programmatic, and 46%
were inter-programmatic collaborations between two or more DF/HCC members. Overall, when counted once,
27% of DF/HCC publications were inter-programmatic collaborations.

## Key facts

- **NIH application ID:** 9842692
- **Project number:** 5P30CA006516-55
- **Recipient organization:** DANA-FARBER CANCER INST
- **Principal Investigator:** Eric P. Winer
- **Activity code:** P30 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2020
- **Award amount:** $73,870
- **Award type:** 5
- **Project period:** — → —

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/9842692

## Citation

> US National Institutes of Health, RePORTER application 9842692, Program 1: Breast Cancer (5P30CA006516-55). Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/grant/nih/9842692. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*